These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18948576)

  • 21. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.
    Le DT; Kong N; Zhu Y; Lauchle JO; Aiyigari A; Braun BS; Wang E; Kogan SC; Le Beau MM; Parada L; Shannon KM
    Blood; 2004 Jun; 103(11):4243-50. PubMed ID: 14982883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.
    Staser K; Park SJ; Rhodes SD; Zeng Y; He YZ; Shew MA; Gehlhausen JR; Cerabona D; Menon K; Chen S; Sun Z; Yuan J; Ingram DA; Nalepa G; Yang FC; Clapp DW
    J Clin Invest; 2013 Jan; 123(1):329-34. PubMed ID: 23221339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated molecular profiling of juvenile myelomonocytic leukemia.
    Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
    Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
    Carratt SA; Braun TP; Coblentz C; Schonrock Z; Callahan R; Curtiss BM; Maloney L; Foley AC; Maxson JE
    Leukemia; 2021 Dec; 35(12):3594-3599. PubMed ID: 34002029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.
    Largaespada DA; Shaughnessy JD; Jenkins NA; Copeland NG
    J Virol; 1995 Aug; 69(8):5095-102. PubMed ID: 7609078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
    Miething C; Grundler R; Mugler C; Brero S; Hoepfl J; Geigl J; Speicher MR; Ottmann O; Peschel C; Duyster J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4594-9. PubMed ID: 17360569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
    Ki DH; He S; Rodig S; Look AT
    Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
    Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
    Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
    Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
    Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.
    Zhang P; He F; Bai J; Yamamoto S; Chen S; Zhang L; Sheng M; Zhang L; Guo Y; Man N; Yang H; Wang S; Cheng T; Nimer SD; Zhou Y; Xu M; Wang QF; Yang FC
    J Clin Invest; 2018 Dec; 128(12):5383-5398. PubMed ID: 30226831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Ecotropic Viral Integration Site 2B (EVI2B) Gene in Juvenile Myelomonocytic Leukemia and Neurofibromatosis Type 1 NF1 Tumors.
    Saharafi P; Akar İ; Ersoy-Evans S; Anlar B; Varan A; Vargel I; Cetin M; Ayter S
    Biochem Genet; 2024 Apr; 62(2):1263-1276. PubMed ID: 37584733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
    Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
    Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice.
    Gutmann DH; Winkeler E; Kabbarah O; Hedrick N; Dudley S; Goodfellow PJ; Liskay RM
    Oncogene; 2003 Jul; 22(29):4581-5. PubMed ID: 12881715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nf1 and Gmcsf interact in myeloid leukemogenesis.
    Birnbaum RA; O'Marcaigh A; Wardak Z; Zhang YY; Dranoff G; Jacks T; Clapp DW; Shannon KM
    Mol Cell; 2000 Jan; 5(1):189-95. PubMed ID: 10678181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1.
    Zhu C; Saberwal G; Lu Y; Platanias LC; Eklund EA
    J Biol Chem; 2004 Dec; 279(49):50874-85. PubMed ID: 15371411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL11A is a SUMOylated protein and recruits SUMO-conjugation enzymes in its nuclear body.
    Kuwata T; Nakamura T
    Genes Cells; 2008 Sep; 13(9):931-40. PubMed ID: 18681895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.
    Ingram DA; Wenning MJ; Shannon K; Clapp DW
    Blood; 2003 Mar; 101(5):1984-6. PubMed ID: 12393498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
    Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F
    N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
    Peng C; Li S
    Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
    Kim A; Morgan K; Hasz DE; Wiesner SM; Lauchle JO; Geurts JL; Diers MD; Le DT; Kogan SC; Parada LF; Shannon K; Largaespada DA
    Blood; 2007 Feb; 109(4):1687-91. PubMed ID: 17090653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.